[Other] Post-remission immunotherapy with vididencel for a measurable residual disease defined high-risk sub-group of adult patients with Acute Myeloid Leukemia in first complete hematological remission: Updated results |
|
This post will be closed automatically in 2026-07-26 00:59
Reward100points
|
post
reply
points
300
20
Optimization of Breast Biopsy and Mastectomy Sample Collection Procedures for Biobanking, Personalized Medicine, and Research Applications
30
Innovation's Last Mile : How BG Characteristics & Governance Shapes Patent Commercialization
50
Intra
20
Structural and electrical characterization of homoepitaxial (102)汕-Ga2O3 layers grown by halide vapor phase epitaxy using synchrotron x-ray topography and emission microscopy
20
Seismicity and Detailed Fault Zone Structure Beneath Haicheng Seismic Zone, NE China: Implications for the Fluid呼nduced Fault Reactivation
